face-scanning software

This Week in Psychedelics - 6.19.20

ThisWeekinPsychedelics.png

Cannabis

  • Louisiana Governor Signs Medical Marijuana Expansion Into Law (Marijuana Moment)

  • Pennsylvania: Supreme Court Rules That Medical Cannabis Use Is Permissible While on Probation (NORML)

  • New Jersey Assembly Approves Marijuana Decriminalization Bill Ahead Of Legalization Referendum (Marijuana Moment)

  • Switzerland releases details on recreational marijuana experiment, but full legalization likely years away (Marijuana Business Daily)

  • Nevada Pardons More Than 15,000 People With Marijuana Convictions Under Governor’s Resolution (Marijuana Moment)

  • Nebraskans hustle to get medical legalization on ballot, with July 3 deadline (Leafly)

  • Science Reveals The Cannabis Industry’s Greatest Lie: You’re Buying Weed Wrong (And So Is Everyone Else) (Forbes)

  • Ohio Marijuana Activists Plan Supreme Court Appeal After Federal Judges Deny Electronic Signature Case (Marijuana Moment)

  • Using cannabis during pregnancy could be bad news for your baby: new research (The Conversation)

  • Library Of Congress Highlights Racist News Coverage Used To Justify Criminalizing Marijuana A Century Ago (Marijuana Moment)

  • Patients Who Use Medical Cannabis Report Being Happier and Healthier Than Those Who Don’t (Grit Daily News)

  • Fed report urges doctors to treat cannabis users as drug addicts (Leafly)

  • Colorado Governor Could Issue Marijuana Pardons Under Social Equity Bill Lawmakers Sent To His Desk (Marijuana Moment)

  • Cannabis Can Increase Intimacy and Reduce Anxiety During Sex, New Study Finds (MERRY JANE)

  • CDC Flooded With Comments On Marijuana And Kratom As Alternative Painkillers Ahead Of Deadline (Marijuana Moment)

  • These 3 Marijuana Nonprofits Are Offering Real Responses To The Pandemic And Racial Injustice (Green Entrepreneur)

  • A Founder Looks at 50: The Important Role of Medical Experts in Support of Legalization (NORML)

  • Lawmakers Push USDA To Let Hemp Farmers Access Coronavirus Relief Funds (Marijuana Moment)

  • Why the Cannabis Sector May be Turning a New Leaf (Investopedia)

Magic Mushrooms

  • Combining therapy with the psychedelic drug psilocybin results in large reductions in anxiety and depression (PsyPost)

  • Colorado Activists Likely To Pursue 2022 Psilocybin Ballot Measure After Poll Shows Support (Marijuana Moment)

  • Numinus receives Health Canada OK for mushrooms research (PressReader)

  • Palliative Canadians endure punishing waits while Health Minister delays approval of Psilocybin mushrooms; TheraPsil expands effort to Ontario (Globe Newswire)

  • A Deep Dive Inside Oregon’s Path to Legalizing Psilocybin Therapy (DoubleBlind)

  • Life Sciences Firm Expands Collaboration Efforts with Major US University to Develop Psilocybin-Based Medicines (StreetWise Reports)

  • New Wave Holdings Corp- Launching the first publicly-traded Psilocybin-growing operation (Value the Markets)

  • Cannabis Company Eyes Medicinal Magic of Mushrooms (Real Money)

  • Psilocybin to Treat Anxiety and Depression in Cancer Patients (Psychedelic Science Review)

  • Cute as Children, but Not Handsome as Adults: María Sabina, Life Magazine, and Cold War Propaganda (Chacruna)

DMT

  • MindMed To Evaluate Ayahuasca's Active Ingredient DMT In Phase 1 Clinical Trial Collaboration (BioSpace)

  • NeonMind Files Patent Application for Therapeutic Use of DMT (Yahoo! Finance)

Ayahuasca

  • Is Ayahuasca Possibly Less than Five Hundred Years Old? (Chacruna)

Iboga

  • Could ibogaine offer a revolutionary long-term solution to addiction? (Health Europa)

Synthetic Cannabinoids

  • New K2 Compound in Canadian Heroin Supply Amid Surging Fatal ODs (Filter)

Nitrous Oxide

  • Nitrous oxide use among young people is increasing in lockdown because it’s cheap and accessible (iNews)

Ketamine

  • Why People are Using Ketamine Nasal Spray to Party (DoubleBlind)

  • High Doses of Ketamine Can Temporarily Shut Down the Brain, Study Finds (MERRY JANE)

  • Champignon’s Dr. Mcintyre / Canadian Rapid Treatment Centre of Excellence (CRTCE) Published in Two Peer Reviewed Study Journals (Globe Newswire)

Miscellaneous

  • UNC to Receive $26.9M from DARPA to Develop Psychiatric Medicines (Psychedelic Science Review)

  • Microsoft reportedly tried to sell facial recognition tech to the DEA (Engadget)

  • Mira X Acquisition Corp. Announces Proposed Qualifying Transaction with Field Trip Psychedelics Inc. (Yahoo! Finance)

  • Fixing American policing also requires an end to the war on drugs (Baker Institute Blog)

  • Champignon Provides Corporate Update; Announces Name Change, Rebranding and Planned Spin Out (Globe Newswire)

  • CFN Enterprises Launches Premier Psychedelics Stock Index Site: PsyIndex.com (Stockhouse)

  • Beyond Stigma: How Researchers May Trigger Drug Users (Filter)

  • Psychedelics Quickly Creating a Potential $100 Billion Market Opportunity (Baystreet)

  • New Wave Holdings Corp Appoints Dr. Dennis McKenna to Psychedelic Research Advisory Board (PR Newswire)

  • Seed crystal: on the contributions of Alexander Shulgin to the science of consciousness (Medium)

  • Psychedelic Medical Start-Up AWAKN Life Sciences Enters the UK Market with Dr. Ben Sessa (Yahoo! Finance)

  • Mota Ventures Appoints Roger C. Clinton as Member of Advisory Board to Verrian GmbH (MarketWatch)

  • L’Chaim Psilocybin: How Psychedelics are Reigniting Judaism (DoubleBlind)

  • Greenstar Biosciences Signs Agreement to Acquire 100% of Eleusian Biosciences Corp. (Yahoo! Finance)

  • 2nd Gen Psychedelic Drugs For Depression Can Be Safer For Older Adults (Forbes)

  • ‘Canada’s first psychedelic-enhanced psychotherapy centre’ changing how we treat depression (GlobalNews)

  • Don’t Get Caught in a Trip Trap; Psychedelic Lessons for this Collective Moment (Lucid News)

  • How psychedelic drugs could help our veterans (9News)

  • Pure Extracts: The Second Wave of Psychedelic Operators (The Deep Dive)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.